【摘要】 采用阿法 D3口服冲击疗法治疗透析患者继发性甲旁亢 (SHPT) 32例 (冲击治疗组 ) ,并与常规疗法 (常规治疗组 )进行比较。结果显示 ,冲击治疗组治疗 8周甲状旁腺素 (PTH)、血磷 (S- P)、AKP明显下降 ,血钙 (S- Ca)明显升高 (P<0 .0 1) ,治疗 12周与 8周无差异 (P>0 .0 5 )。提示阿法 D3口服冲击治疗透析患者 SHPT优于常规疗法。更多还原

【Abstract】 WT5”BZ]32 cases of dialysis patients(group A)with secondary hyperparathyroidism(SHPT)to urinemia were treated with pulse dose α(OH)D 3 and they were compared with another group(groupB)who accepted small daily dose α(OH)D 3 Results showed that blood serum parathyroid hormone(PTH),Serum P and AKP decreased significantly,serum Ca 2+ increased significantly at the end of 8 weeks in groupA(P<0 01) 12 weeks later there were no significant changes compared with the end of 8 weeks(P>0 05) This suggested that pulse dose α(OH)D 3 was more valuable than small daily dose in the treatment of SHPT dialysis patients [WT5”HZ]更多还原